miltefosine has been researched along with erucylphosphocholine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jolliffe, KA; Obando, D; Sorrell, TC; Widmer, F; Wright, LC | 1 |
| Alam, MM; Hong, J; Joh, EH; Kim, B; Kim, DH; Kim, Y; Lee, YS; Oh, YI | 1 |
| Eibl, H; Kötting, J; Reitz, RC; Unger, C | 1 |
| Berger, MR; Eibl, H; Kötting, J; Unger, C | 1 |
| Berger, MR; Eibl, H; Kaufmann-Kolle, P; Unger, C | 1 |
| Berger, MR; Eibl, H; Konstantinov, SM | 1 |
| van Blitterswijk, WJ; Verheij, M | 1 |
| Dynarowicz-Łątka, P; Kwiatek, W; Lipiec, E; Wnętrzak, A; Łątka, K | 1 |
| Dakir, EL; Dakir, el H; López-Abán, J; Mollinedo, F; Muro, A; Varela-M, RE; Yepes, E | 1 |
| Cabello, J; Mohler, WA; Mollinedo, F; Reis-Sobreiro, M; Rodríguez-Matellán, AG; Sáenz-Narciso, B; Sánchez-Blanco, A | 1 |
1 review(s) available for miltefosine and erucylphosphocholine
| Article | Year |
|---|---|
Anticancer mechanisms and clinical application of alkylphospholipids.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Membrane; Endocytosis; Humans; Neoplasms; Organophosphates; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Phospholipid Ethers; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Quaternary Ammonium Compounds; Signal Transduction | 2013 |
9 other study(ies) available for miltefosine and erucylphosphocholine
| Article | Year |
|---|---|
Synthesis, antifungal and antimicrobial activity of alkylphospholipids.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Erythrocytes; Fungi; Molecular Structure; Phospholipids; Structure-Activity Relationship | 2007 |
Synthesis and biological evaluation of cyclopentane-linked alkyl phosphocholines as potential anticancer agents that act by inhibiting Akt phosphorylation.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cyclopentanes; Humans; Inhibitory Concentration 50; Phosphorylation; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Stereoisomerism | 2012 |
Comparison of the tissue distribution of hexadecylphosphocholine and erucylphosphocholine.
Topics: Animals; Antineoplastic Agents; Female; Phosphorylcholine; Rats; Rats, Wistar; Tissue Distribution | 1992 |
Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations.
Topics: Animals; Antineoplastic Agents; Cell Division; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Male; Mammary Neoplasms, Experimental; Methylnitrosourea; Phosphatidylcholines; Phosphorylcholine; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Tissue Distribution | 1992 |
Systemic administration of alkylphosphocholines. Erucylphosphocholine and liposomal hexadecylphosphocholine.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Area Under Curve; Half-Life; Injections, Intravenous; Liposomes; Mammary Neoplasms, Experimental; Phosphorylcholine; Rats; Rats, Sprague-Dawley; Rats, Wistar; Tumor Cells, Cultured | 1996 |
BCR-ABL influences the antileukaemic efficacy of alkylphosphocholines.
Topics: Apoptosis; Cell Adhesion; Cell Survival; Dose-Response Relationship, Drug; Fusion Proteins, bcr-abl; HL-60 Cells; Humans; Molecular Structure; Phosphorylcholine; Structure-Activity Relationship; Tumor Cells, Cultured | 1999 |
Affinity of alkylphosphocholines to biological membrane of prostate cancer: studies in natural and model systems.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Membrane; Humans; Male; Models, Biological; Phosphorylcholine; Prostatic Neoplasms | 2014 |
In vitro and in vivo anti-schistosomal activity of the alkylphospholipid analog edelfosine.
Topics: Animals; Antineoplastic Agents; Antiparasitic Agents; Apoptosis; Female; Mice; Phospholipid Ethers; Phosphorylcholine; Schistosoma mansoni; Schistosomiasis mansoni | 2014 |
Caenorhabditis elegans as a platform to study the mechanism of action of synthetic antitumor lipids.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caenorhabditis elegans; Cell Line, Tumor; Cholesterol; Drug Resistance; Embryo, Nonmammalian; Embryonic Development; Humans; Insulin-Like Growth Factor I; Larva; Membrane Microdomains; Phospholipid Ethers; Phosphorylcholine | 2014 |